Teva Pharmaceuticals, the world’s largest maker of generic drugs, plans to eliminate about 5,000 jobs as it accelerates cost reductions.
Cutbacks, which equal about 10 percent of the workforce, will yield annual cost savings of about $2 billion by the end of that year, the company said.
Teva did not disclose where the cuts would happen. It employs some 1,000 people in Ireland.
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
Then €19.99 a month after the offer period.
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Get a Business Account for you and your team